ACUTE KIDNEY INJURY (AKI)-NSAIDs

From NeuroRehab.wiki

Revision as of 20:03, 13 March 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. Pre-renal failure - by inhibiting prostaglandin production, leading to decreased glomerular perfussion pressure.

2. Hyperkalemia - due to inhibition of renin release from JG apparatus, leading to low aldosterone, due to reduced K+ excreation.

3. NSAIDs also can cause an acute or a chronic interstitial nephritis, with nephrotic-range proteinuria (common) and papillary necrosis (rare).


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].

Retrieved from "https://www.neurorehab.wiki/index.php?title=ACUTE_KIDNEY_INJURY_(AKI)-NSAIDs&oldid=18009"